Inovio Pharmaceuticals Inc. (INO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Inovio Pharmaceuticals In...

    NASDAQ: INO · Real-Time Price · USD
    2.79
    0.04 (1.45%)
    At close: Sep 05, 2025, 3:59 PM
    2.85
    2.15%
    After-hours: Sep 05, 2025, 07:38 PM EDT

    Inovio Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 217.76K 832.01K 10.26M 1.77M
    Cost of Revenue
    		 3.13M 3.5M 5.5M 4.73M
    Gross Profit
    		 -2.91M -2.67M 4.77M -2.96M
    Operating Income
    		 -112.4M -143.94M -267.57M -301.22M
    Interest Income
    		 4.77M 8.13M 4.78M 3.36M
    Pretax Income
    		 -107.25B -135.12M -277.65M -303.22M
    Net Income
    		 -107.25M -135.12M -279.82M -303.66M
    Selling & General & Admin
    		 37B 47.58M 90.19M 53.75M
    Research & Development
    		 75.62B 86.68M 187.65M 249.24M
    Other Expenses
    		 n/a -1.7M n/a n/a
    Operating Expenses
    		 112.62B 132.56M 277.84M 302.99M
    Interest Expense
    		 177.83K 1.22M 1.25M 1.94M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 112.62M 136.06M 284.54M 302.99M
    Income Tax Expense
    		 -107.15B n/a 2.17M 434.39K
    Shares Outstanding (Basic)
    		 27.16M 22.17M 19.89M 214.62M
    Shares Outstanding (Diluted)
    		 27.16M 22.17M 19.89M 214.62M
    EPS (Basic)
    		 -3.95 -6.09 -14.07 -1.42
    EPS (Diluted)
    		 -3.95 -6.09 -14.07 -1.42
    EBITDA
    		 -103.95M -130.39M -270.9M -296.56M
    EBIT
    		 -107.08M -133.89M -276.4M -301.29M
    Depreciation & Amortization
    		 3.13M 3.5M 5.5M 4.73M

    Add to Watchlist